treatmentoptions4u.com

Asunra (Deferasirox) Tablet available Delhi, Mumbai, Madras, Hyderabad, Bangalore India

Asunra (Deferasirox) Tablet

Generic brands for Vinblastine Injection Available in India Brand Name Vilban Generic Name Vinblastine Strength 10mg Manufacturer Miracalus Pharma Pvt Ltd

Category: , ,
Tags:

Description

Description

This page contains brief details about the drug deferasirox, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Deferasirox is an iron chelator that was approved for its medical use on 2nd November 2005.

Mechanism of Action of Deferasirox

Deferasirox Tablet is an agent isolated from the microorganism Streptomyces pilosus. It forms a chelate with iron that is eliminated by the kidneys and reduces cardiac iron overload.

Uses of Deferasirox

Deferasirox Tablet has been developed to remove excess iron from the body. It is indicated to treat chronic iron overload due to blood transfusion and non-transfusion-dependent thalassemia.

Deferasirox Dosage available

Deferasirox is available as tablets in the doses 100mg, 180mg, 250mg, 360mg, 400mg and 500mg. your healthcare provider will prescribe the accurate dose depending on your body weight and medical condition. Swallow Deferasirox Tablet with water or other fluids at the same time each day. Take Deferasirox on an empty stomach or after light meals.

We can ship to :

News/Updates

References

  1. Hospira UK Limited, Electronic medicines compendium (EMC), [Revised on Sept 2020][ Accessed on 4th April 2023], https://www.medicines.org.uk/emc/files/pil.1422.pdf
  2. DBL vinblastine injection – pfizer. Available at: https://labeling.pfizer.com/ShowLabeling.aspx?id=12288 [ Accessed on 4th April 2023].
  3. Vinblastine injection -NPS MedicineWise. Available at: https://www.nps.org.au/assets/medicines/aea96da5-9c46-482b-9add-a53300ff05d1.pdf   [ Accessed on 4th April 2023].
  4. HY Yap; Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer; Cancer Treatment Reports; Published on March 1980;[ Accessed on 4th April 2023]; https://pubmed.ncbi.nlm.nih.gov/7407762/
  5. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1706.
  6. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 865.

Related products